To Our Doctors, Patients and Clients,
On behalf of Coast Reproductive and Coast Science, I would like to thank you for making 2009 a great year! Your continued use and support of our products has provided an avenue of growth through an economically challenging time. Although we made some necessary adjustments during the course of the year, our group remains focused on providing the highest level of service and products to our clients. We remained focused on continuing support of patient advocacy through education and research. The Coast Companies are dedicated to research and education through the founding of the Traveling Scholars Program for the Society for Male Reproduction and Urology and the Nursing Fellowship Fund for the Society for the Study of Male Reproduction. Both programs are in place to help offset the rising costs of education for professionals in the Urological and Reproductive Health fields.
In 2006 we marked the successful introduction of the Coast Reproductive Male Fertility Supplement (MFS), the successor to Fertile One™, as well as two new products for pregnancy and prenatal support. Since the inception of these products we have helped over 30,000 patients. In 2009, our product will take on a new look and name. The Male Prenatal™ will utilize the same science as it’s predecessor, MFS, and be more readily identifiable as the product that all men should take to prepare for conception as well as fertility treatment. A better sample with lower levels of DNA Fragmentation and better overall sperm integrity will assist the fertility process, from the patient to the laboratory to conception and most importantly to the take home baby.
In addition, Coast Science is delighted to announce the release of Total Fertility™, a new proprietary supplement, which has been proven to help previously unsuccessful IVF patients achieve pregnancy. In an August 2009 publication at the Society of Reproductive Biology, the authors reported on a study in which 17 of 18 women who had prior failed IVF, achieved a successful IVF outcome (defined as a positive chemical pregnancy and clinical pregnancy) through integrating Total Fertility with a subsequent IVF treatment. Patients selected for participation in the study had, on average, two prior failed IVF attempts in which Total Fertility was not a part of their treatment plan. As a leader in nutritional science, Coast Science has developedTotal Fertility for IVF patients, as well as women preparing for fertility treatment. It can also be taken as a prenatal supplement following IVF treatment. It has been designed to encourage blood flow, and improve egg and embryo quality. Total Fertility is available as a convenient, easy to swallow capsule.
Our Prostatitis Relief product continues to help those suffering from chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), Prostatitis Reliefincludes: Quercetin, Relora® and Lycopene, all selected for their ability to relieve the symptoms of CP/CPPS.
Coast Reproductive is anticipating a number of exciting developments in 2009. We will be launching a new product in early 2009 focused on cancer prevention, BPH, and overall prostate health. Our 2009 line up will also include the introduction of a several products formulated to help families lead healthy lives. We will make sure to inform you of all the developments.
We have also enhanced our services with the addition of a National Nursing Advisor and a Client Services Manager to facilitate questions about our products from doctors and patients. As leading nutritional science companies, dedicated to “better health through science”, Coast Reproductive and Coast Science are committed to providing you and your patients with unique formulations manufactured to the highest industry standards. Founded in 2001, Coast Reproductive® is committed to helping couples conceive the miracle of life and helping families live healthy lives.
I wish you the happiest of times and look forward to a continued positive relationship with you for the coming new year and the future.
Thank you,
Bruce J. Thomsen
Chairman and Chief Executive Officer
